Eric Aguiar

Insider Reports History

Entity
Individual
Location
888 7 Th Avenue, 12 Th Floor, New York, NY
Signature
/s/ Brian C. Stephenson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Aguiar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Invitae Corp Director Common Stock 125K $81.2K $0.65 Apr 27, 2023 Direct
Biomea Fusion, Inc. Director Stock Option (Right to Buy) 51K Jun 12, 2024 Direct
Invitae Corp Director Stock Option (right to buy) 28.9K Apr 27, 2023 Direct
BridgeBio Pharma, Inc. Director Stock Option (Right to Buy) 26K Jun 21, 2024 Direct

Insider Reports Filed by Eric Aguiar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBIO BridgeBio Pharma, Inc. Jun 21, 2024 1 $0 4 Jun 25, 2024 Director
BMEA Biomea Fusion, Inc. Jun 12, 2024 1 $0 4 Jun 13, 2024 Director
BBIO BridgeBio Pharma, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
BMEA Biomea Fusion, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
NVTA Invitae Corp Apr 27, 2023 2 $0 4 May 1, 2023 Director
BMEA Biomea Fusion, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
BBIO BridgeBio Pharma, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
NVTA Invitae Corp Apr 28, 2022 4 $0 4 May 2, 2022 Director
BBIO BridgeBio Pharma, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director